Next |
home / stock / bbio / bbio message board
Subject | By | Source | When |
---|---|---|---|
Offering comign | Pt3 | investorshub | 03/06/2023 4:47:20 PM |
BridgeBio Announces Positive Phase 2 Cohort 5 Results | 02opida | investorshub | 03/06/2023 4:21:16 PM |
BridgeBio Announces Positive Phase 2 Cohort 5 Results | subslover | investorshub | 03/06/2023 1:34:59 PM |
Recent Trades - Last 10 of 1063 | 02opida | investorshub | 12/08/2022 4:21:10 PM |
volume will start to pickup | 02opida | investorshub | 08/09/2022 6:09:28 PM |
PALO ALTO, Calif., May 13, 2022 (GLOBE NEWSWIRE) | 02opida | investorshub | 08/05/2022 7:27:31 PM |
https://www.stockwatch.com/News/Item/U-z8612485-U!$BBIO-20220804/U/$BBIO | 02opida | investorshub | 08/05/2022 3:45:07 PM |
PALO $ALTO, Calif., May 20, 2022 (GLOBE NEWSWIRE) | 02opida | investorshub | 05/20/2022 12:02:11 PM |
PALO $ALTO, Calif., May 17, 2022 (GLOBE NEWSWIRE) | 02opida | investorshub | 05/17/2022 12:03:22 PM |
BridgeBio Pharma Reports Sale Of Rare Pediatric Disease | crudeoil24 | investorshub | 05/13/2022 11:57:26 AM |
LET'S GO $BBIO > $$$$$ | crudeoil24 | investorshub | 05/12/2022 2:03:55 PM |
BridgeBio Eligible To Receive Up To $905M From | crudeoil24 | investorshub | 05/12/2022 1:52:06 PM |
PALO ALTO and SOLANA BEACH, Calif., March 08, | 02opida | investorshub | 03/08/2022 1:21:24 PM |
NEWS | 02opida | investorshub | 02/24/2022 1:08:09 PM |
PALO ALTO, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) | 02opida | investorshub | 01/27/2022 1:01:10 PM |
The Calm before the Storm North | 02opida | investorshub | 01/18/2022 2:01:35 PM |
morning $BBIO | 02opida | investorshub | 01/18/2022 2:00:59 PM |
PALO ALTO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) | 02opida | investorshub | 01/13/2022 1:37:06 PM |
Gap n slap | BigFortune | investorshub | 01/03/2022 1:00:21 PM |
#$BBIO ?? Price dropped 70% & since | da_stock_analyst | investorshub | 01/02/2022 10:52:44 PM |
News, Short Squeeze, Breakout and More Instantly...
BridgeBio Pharma Inc. Company Name:
BBIO Stock Symbol:
NYSE Market:
2024-04-09 22:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- In this exploratory substudy, treatment with acoramidis was associated with possible cardiac structural and functional improvement compared with placebo, with potential cardiac amyloid regression - The data demonstrate that targeting near-complete transthyretin (TTR) stabilization wit...
2024-03-20 22:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...